Abstract Cerebral Amyloid Angiopathy (CAA) is a neurological disorder characterized by the
deposition of amyloid plaques in the walls of cerebral blood vessels. This condition poses …

Drug transporters play an important role in the maintenance of chemical balance and
homeostasis in different tissues. In addition to their physiological functions, they are crucial …

Integrating cerebrospinal fluid-biomarkers into diagnostic workup of patients with sporadic
cerebral amyloid angiopathy may support early and correct identification. We aimed to …

Plasma amyloid beta (Aβ) and tau are emerging as accessible biomarkers for Alzheimer's
disease (AD). However, many assays exist with variable test performances, highlighting the …

Background and purpose: Sporadic cerebral amyloid angiopathy (CAA) is a small vessel
disease, resulting from progressive amyloid-β deposition in the media/adventitia of cortical …

Background Cerebral amyloid angiopathy (CAA) pathology is becoming increasingly
important in Alzheimer's disease (AD) because of its potential link to amyloid-related …

Cerebral amyloid angiopathy (CAA) is a type of cerebrovascular disorder characterised by
the accumulation of amyloid within the leptomeninges and small/medium-sized cerebral …

Brain amyloid‐β (Aβ) deposits are key pathological hallmarks of both cerebral amyloid
angiopathy (CAA) and Alzheimer's disease (AD). Microvascular deposits in CAA mainly …

Introduction: There are limited data regarding cerebrospinal fluid (CSF) and plasma
biomarkers among patients with Cerebral Amyloid Angiopathy (CAA). We sought to …

Anti-amyloid therapies (AATs), such as anti-amyloid monoclonal antibodies, are emerging
treatments for people with early Alzheimer's disease (AD). AATs target amyloid β plaques in …